Dr. Ann Marie Ruhe is a clinical pharmacist at Sheppard Pratt Health System. Dr. Ruhe collaborates in the management of medication regimens for patients with psychiatric diagnoses on the child and adolescent inpatient service line, which includes a 16-bed child unit, a 20-bed male adolescent unit, a 20-bed female adolescent unit, and a 14-bed neuropsychiatric unit. She also leads a weekly medication education group for patients on the adolescent female unit as well as a guardian-focused medication education group for the entire child and adolescent service line. In addition to her patient care roles, Dr. Ruhe contributes to the Sheppard Pratt Pharmacy Phacts newsletter and serves on both the Pharmacy and Therapeutics Committee and Infection Control Committee. Dr. Ruhe serves as a Clinical Assistant Professor at the University of Maryland School of Pharmacy and peer reviewer for both the Annals of Pharmacotherapy and the Mental Health Clinician. She will begin her term on the Editorial Board of the Mental Health Clinician in April 2019.
Dr. Ruhe earned her Doctor of Pharmacy at Ohio Northern University Raabe College of Pharmacy. She completed her PGY1 pharmacy practice residency at the University of Cincinnati Medical Center and PGY2 psychiatric pharmacy residency at the Medical University of South Carolina. Dr. Ruhe has also completed the academician preparedness program at the Medical University of South Carolina as well as the teaching certificate program at the University of Cincinnati. She is licensed to practice pharmacy in Maryland, South Carolina, and Ohio and is a board certified psychiatric pharmacist.
Ohio Northern University Raabe College of Pharmacy
Primary Care: University of Cincinnati Medical Center
Psychiatry: Medical University of South Carolina
College of Psychiatric and Neurologic Pharmacists (CPNP): 2016 – present
Ruhe AM, Qureshi I, Procaccini D. (2018). Clozapine-induced myocarditis in an adolescent male with DiGeorge Syndrome. Ment Health Clin [Internet], 8(6):313-6.
Ruhe AM, Hebbard A, Hayes G. (2018). Assessment of venous thromboembolism risk and initiation of appropriate prophylaxis in psychiatric patients. Ment Health Clin [Internet], 8(2):68-72.
Cooler J, Ross CA, Robert S, Linder L, Ruhe AM, Philip A. (2019). Evaluation and optimization of take-home naloxone in an academic medical center. Ment Health Clin [Internet].